PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.81%
Revenue growth under 50% of OGI.TO's 54.41%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
23.28%
Gross profit growth under 50% of OGI.TO's 201.24%. Michael Burry would be concerned about a severe competitive disadvantage.
119.76%
EBIT growth 1.25-1.5x OGI.TO's 100.56%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
119.76%
Operating income growth 1.25-1.5x OGI.TO's 100.56%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-0.34%
Negative net income growth while OGI.TO stands at 96.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
5.93%
EPS growth under 50% of OGI.TO's 84.21%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.76%
Diluted EPS growth under 50% of OGI.TO's 84.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
Negative OCF growth while OGI.TO is at 13.03%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-24.62%
Negative FCF growth while OGI.TO is at 5.72%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
729.33%
3Y revenue/share CAGR 1.25-1.5x OGI.TO's 527.22%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-5193.14%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-372.30%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-681.49%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1634.96%
10Y net income/share CAGR of 1634.96% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2589.28%
5Y net income/share CAGR above 1.5x OGI.TO's 65.57%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
428.42%
3Y net income/share CAGR above 1.5x OGI.TO's 36.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
6077.40%
Equity/share CAGR of 6077.40% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
14361.42%
5Y equity/share CAGR above 1.5x OGI.TO's 1475.71%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
589.54%
3Y equity/share CAGR above 1.5x OGI.TO's 264.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.59%
AR growth well above OGI.TO's 19.40%. Michael Burry fears inflated revenue or higher default risk in the near future.
24.96%
Inventory growth well above OGI.TO's 10.03%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.90%
Asset growth well under 50% of OGI.TO's 9.56%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.53%
Under 50% of OGI.TO's 302.22%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.79%
We’re deleveraging while OGI.TO stands at 74.20%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
135.68%
R&D growth drastically higher vs. OGI.TO's 26.02%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.34%
We expand SG&A while OGI.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.